Page 23 - 2019_06-Haematologica-web

Editorials
vance. However, in spite of this, the manuscript of Vollenberg et al.4 opens new fields of investigation con- cerning the evaluation of the mechanisms involved in immune thrombocytopenia and the bleeding tendency of the patients affected.
References
1. Kiefel V, Santoso S, Kaufmann E, Mueller-Eckhardt C. Autoantibodies against platelet glycoprotein Ib/IX: a frequent find- ing in autoimmune thrombocytopenic purpura. Br J Haematol. 1991;79(2):256-262.
2. Noris P, Balduini CL. Inherited thrombocytopenias in the era of per- sonalized medicine. Haematologica. 2015;100(2):145-148.
3. BastidaJM,LozanoML,BenitoR,etal.Introducinghigh-throughput sequencing into mainstream genetic diagnostic practice in inherited platelet disorders. Haematologica. 2018;103(1):148-162.
4. Vollenberg,R,JouniR,NorrisPAA,etal.GlycoproteinVisarelevant immune target in patients with immune thrombocytopenia. Haematologica. 2019;104(6):1237-1243.
5. Ulsemer P, Strassel C, Baas MJ, et al. Biosynthesis and intracellular post-translational processing of normal and mutant platelet glyco- protein GPIb-IX. Biochem J. 2001;358(Pt 2):295-303.
6. Li CQ, Dong JF, Lanza F, Sanan DA, Sae-Tung G, Lopez JA. Expression of platelet glycoprotein (GP) V in heterologous cells and evidence for its association with GPIbalpha in forming a GPIb-IX-V complex on the cell surface. J Biol Chem. 1995;270(27):16302-16307.
7. Savoia A, Pastore A, DE Rocco D, et al. Clinical and genetic aspects of Bernard-Soulier syndrome: searching for genotype/phenotype correlations. Haematologica. 2011;96(3):417-423.
8. Poujol C, Ramakrishnan V, DeGuzman F, Nurden AT, Phillips DR, Nurden P. Ultrastructural analysis of megakaryocytes in GPV knock- out mice. Thromb Haemost. 2000;84(2):312-318.
9. McMillan R. The pathogenesis of chronic immune thrombocy- topenic purpura. Semin Hematol. 2007;44(4 Suppl 5):S3-S11.
10. Li J, van der Wal DE, Zhu G, et al. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nat Commun. 2015;6:7737.
11. Jansen AJ, Josefsson EC, Rumjantseva V, et al. Desialylation acceler- ates platelet clearance after refrigeration and initiates GPIbα metal- loproteinase-mediated cleavage in mice. Blood. 2012;119(5):1263- 1273.
12. Quach ME, Dragovich MA, Chen W, et al. Fc-independent immune thrombocytopenia via mechanomolecular signaling in platelets. Blood. 2018;131(7):787-796.
13. Poujol C, Bergmeier W, Nurden P, et al. Effect of infusing rat mono- clonal antibodies to the murine GPIb-IX-V complex on platelet and megakaryocyte morphology in mice. Platelets. 2003;14(1):35-45.
14. Bender M, Stegner D, Nieswandt B. Model systems for platelet receptor shedding. Platelets. 2017;28(4):325-332.
15. Ravanat C, Freund M, Mangin P, et al. GPV is a marker of in vivo platelet activation--study in a rat thrombosis model. Thromb Haemost. 2000;83(2):327-333.
16. Kahn ML, Diacovo TG, Bainton DF, Lanza F, Trejo J, Coughlin SR. Glycoprotein V-deficient platelets have undiminished thrombin responsiveness and do not exhibit a Bernard-Soulier phenotype. Blood. 1999; 94(12):4112-4121.
17. Ramakrishnan V, Reeves PS, DeGuzman F, et al. Increased thrombin responsiveness in platelets from mice lacking glycoprotein V. Proc Natl Acad Sci USA 1999;96(23):13336-13341.
18. Moog S, Mangin P, Lenain N, et al. Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood. 2001;98(4):1038-1046.
19. Nonne C, Hechler B, Cazenave JP, et al. Reassessment of in vivo thrombus formation in glycoprotein V deficient mice backcrossed on a C57Bl/6 strain. J Thromb Haemost. 2008;6(1):210-212.
20. Porcelijn L, Huiskes E, Oldert G, et al. Detection of platelet autoan- tibodies to identify immune thrombocytopenia: state of the art. Br J Haematol. 2018;182(3):423-426.
haematologica | 2019; 104(6)
1105